Patent · US Active

Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine

US8207197B2 · kind B2 · utility

3Cited by

3References

10Claims

0Family size

Assignee

BIOPROJET · FR

Inventors

Manuel Raga · Barcelona, ES
Juan Sallares · Sant Cugat del Vallès, ES
Marta Guerrero · Barcelona, ES
Antonio Guglietta · Molins de Rei, ES
Jean-Michel Arrang · Gif-sur-Yvette, FR
Jean-Charles Schwartz · Paris, FR
Holger Stark · Bad Homburg vor der Höhe, DE
Walter Schunack · Berlin, DE
Xavier Ligneau · Brive-la-Gaillarde, FR
Jeanne-Marie Lecomte · Paris, FR
Charon Ganellin · Thame, GB

Key dates

Filing date	Feb 6, 2006
Grant date	Jun 26, 2012
Priority date	—
Expiry date	Feb 25, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, the respective manufacture and methods of use, and compositions containing such a compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.